2009
DOI: 10.1016/j.tiv.2008.09.017
|View full text |Cite
|
Sign up to set email alerts
|

In silico prediction of mitochondrial toxicity by using GA-CG-SVM approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
38
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 65 publications
(40 citation statements)
references
References 29 publications
2
38
0
Order By: Relevance
“…Finally 246 tested drugs and drug like molecules from the publication by Zhang et al . were added to the collected data . The labels “active” and “inactive” were adapted from the publication.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Finally 246 tested drugs and drug like molecules from the publication by Zhang et al . were added to the collected data . The labels “active” and “inactive” were adapted from the publication.…”
Section: Methodsmentioning
confidence: 99%
“…A disadvantage, however, is the lack of suitable, large datasets which might serve as basis for predictive machine learning models. The two biggest published data sets for mitochondrial toxicity are the Zhang data set (246 compounds) and the Tox21 dataset (5403 compounds). The Tox21 dataset originates from the Tox21 challenge where the mitochondrial membrane potential was assessed in a high throughput screening assay .…”
Section: Introductionmentioning
confidence: 99%
“…[13][14][15][19][20][21] However, very few profilers have dealt with toxicity induced by mitochondrial dysfunction. 1,22,23 This is, in part, due to the number of mechanisms by which a chemical could induce mitochondrial dysfunction 24 . An additional complication is that a single chemical might have the ability to induce more than one of these mechanisms, making it difficult to define a single MIE within the AOP paradigm.…”
Section: -12mentioning
confidence: 99%
“…[1][2][3][4][5][6][7] These alternatives have been developed employing in silico, in chemico and in vitro methods focussing on replacing or reducing animals used in short-term toxicity tests 8 . In order to be relevant, and useful, for regulatory assessment these alternatives should be based upon specific in vivo endpoints.…”
Section: Introductionmentioning
confidence: 99%
“…A three-stage manual descriptor selection process was performed: (1) descriptors with too many zero values or the same values (descriptors of Tween HS) were eliminated; (2) descriptors with very small standard deviation values (<0.5%) were removed; (3) a particular descriptor was chosen to represent a group of highly correlated variables (correlation coefficients >0.80), thereby minimizing the redundancy and overlapping of the descriptors. Since the ranges of descriptor values influence the quality of the models generated, we normalized the rest descriptor values to a range of 0 to 1 [28].…”
Section: Solubility Studiesmentioning
confidence: 99%